Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -204,627 | -567,939 | -75,802 | -104,199 | -86,848 |
| Depreciation Amortization | 2,401 | 683 | 222 | 199 | 184 |
| Accounts receivable | -3,354 | -12,722 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,131 | -1,654 | 70 | -1,786 | 1,861 |
| Other Working Capital | -11,979 | -12,507 | 540 | -3,447 | 4,793 |
| Other Operating Activity | 41,001 | 463,726 | 6,971 | 13,125 | 11,820 |
| Operating Cash Flow | $-173,427 | $-130,413 | $-67,999 | $-96,108 | $-68,190 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 107,874 | 110,437 | 8,976 | 63,814 | -454,387 |
| PPE Investments | -354 | -162 | -55 | -357 | -282 |
| Net Acquisitions | N/A | 19,862 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -8,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -8,000 | -7,434 | 0 | 0 | 0 |
| Investing Cash Flow | $99,520 | $122,703 | $8,921 | $63,457 | $-454,669 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,102 | 12,609 | N/A | N/A | N/A |
| Debt Repayment | -11,899 | -17,163 | N/A | N/A | N/A |
| Common Stock Issued | 11,421 | 4,885 | 628 | 1,327 | 758 |
| Other Financing Activity | 142,911 | 0 | 0 | 0 | 624,769 |
| Financing Cash Flow | $202,535 | $331 | $628 | $1,327 | $625,527 |
| Exchange Rate Effect | -265 | 453 | N/A | N/A | N/A |
| Beginning Cash Position | 35,723 | 42,649 | 101,099 | 132,423 | 29,755 |
| End Cash Position | 164,086 | 35,723 | 42,649 | 101,099 | 132,423 |
| Net Cash Flow | $128,363 | $-6,926 | $-58,450 | $-31,324 | $102,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -173,427 | -130,413 | -67,999 | -96,108 | -68,190 |
| Capital Expenditure | -354 | -162 | -69 | -370 | -282 |
| Free Cash Flow | -173,781 | -130,575 | -68,068 | -96,478 | -68,472 |